Mikhailenko I, Krylov D, Argraves K M, Roberts D D, Liau G, Strickland D K
Holland Laboratory, American Red Cross, Rockville, Maryland 20855, USA.
J Biol Chem. 1997 Mar 7;272(10):6784-91. doi: 10.1074/jbc.272.10.6784.
Thrombospondin-1 (TSP-1) is a large modular trimeric protein that has been proposed to play a diverse role in biological processes. Newly synthesized TSP-1 either is incorporated into the matrix or binds to the cell surface where it is rapidly internalized and degraded. TSP-1 catabolism is mediated by the low density lipoprotein receptor-related protein (LRP), a large endocytic receptor that is a member of the low density lipoprotein receptor family. Using adenovirus-mediated gene transfer experiments, we demonstrate that the very low density lipoprotein receptor can also bind and internalize TSP-1. An objective of the current investigation was to identify the portion of TSP-1 that binds to these endocytic receptors. The current studies found that the amino-terminal heparin binding domain (HBD, residues 1-214) of mouse TSP-1, when prepared as a fusion protein with glutathione S-transferase (GST), bound to purified LRP with an apparent KD ranging from 10 to 25 nM. Recombinant HBD (rHBD) purified following proteolytic cleavage of GST-HBD, also bound to purified LRP, but with an apparent KD of 830 nM. The difference in affinity was attributed to the fact that GST-HBD exists in solution as a dimer, whereas rHBD is a monomer. Like TSP-1, 125I-labeled GST-HBD or 125I-labeled rHBD were internalized and degraded by wild type fibroblasts that express LRP, but not by fibroblasts that are genetically deficient in LRP. The catabolism of both 125I-labeled GST-HBD and rHBD in wild type fibroblast was blocked by the 39-kDa receptor-associated protein, an inhibitor of LRP function. GST-HBD and rHBD both completely blocked catabolism of 125I-labeled TSP-1 in a dose-dependent manner, as did antibodies prepared against the HBD. Taken together, these data provide compelling evidence that the amino-terminal domain of TSP-1 binds to LRP and thus the recognition determinants on TSP-1 for both LRP and for cell surface proteoglycans reside within the same TSP-1 domain. Further, high affinity binding of TSP-1 to LRP likely results from the trimeric structure of TSP-1.
血小板反应蛋白-1(TSP-1)是一种大型模块化三聚体蛋白,有人提出它在生物过程中发挥多种作用。新合成的TSP-1要么整合到基质中,要么与细胞表面结合,在细胞表面它会迅速内化并降解。TSP-1的分解代谢由低密度脂蛋白受体相关蛋白(LRP)介导,LRP是一种大型内吞受体,属于低密度脂蛋白受体家族。通过腺病毒介导的基因转移实验,我们证明极低密度脂蛋白受体也能结合并内化TSP-1。当前研究的一个目标是确定TSP-1中与这些内吞受体结合的部分。目前的研究发现,小鼠TSP-1的氨基末端肝素结合域(HBD,第1至214位氨基酸残基),当与谷胱甘肽S-转移酶(GST)作为融合蛋白制备时,与纯化的LRP结合,其表观解离常数(KD)范围为10至25 nM。在GST-HBD经蛋白酶切割后纯化得到的重组HBD(rHBD)也与纯化的LRP结合,但其表观KD为830 nM。亲和力的差异归因于GST-HBD在溶液中以二聚体形式存在,而rHBD是单体。与TSP-1一样,125I标记的GST-HBD或125I标记的rHBD被表达LRP的野生型成纤维细胞内化并降解,但不被LRP基因缺陷的成纤维细胞内化和降解。野生型成纤维细胞中125I标记的GST-HBD和rHBD的分解代谢都被39 kDa受体相关蛋白阻断,该蛋白是LRP功能的抑制剂。GST-HBD和rHBD都以剂量依赖的方式完全阻断了125I标记的TSP-1的分解代谢,针对HBD制备的抗体也有同样的效果。综上所述,这些数据提供了令人信服的证据,表明TSP-1的氨基末端结构域与LRP结合,因此TSP-1上LRP和细胞表面蛋白聚糖的识别决定簇位于同一TSP-1结构域内。此外,TSP-1与LRP的高亲和力结合可能源于TSP-1的三聚体结构。